
Park Ha Biological Technology Co., Ltd.
PHHNASDAQConsumer Defensive
$0.39
$-0.00(-0.08%)
Market Cap$9960058
P/E Ratio—
52W High$41.49
52W Low$0.331
Park Ha Biological Technology Co., Ltd.(PHH)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · PHH · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-10 | 2023-10 | 2022-10 | 2021-10 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.38M | $2.46M | $1.92M | $0.93M | $456.00M |
| Cost of Revenue | $0.20M | $0.31M | $0.51M | $0.31M | $0.00M |
| Gross Profit | $2.19M | $2.15M | $1.41M | $0.62M | $456.00M |
| Gross Margin %(computed) | 91.81% | 87.35% | 73.47% | 66.58% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.04M | $0.03M | $0.06M | $0.00M | $0.00M |
| G&A Expenses | $0.81M | $0.48M | $0.71M | $0.75M | $294.00M |
| Total Operating Expenses | $1.39M | $0.97M | $1.21M | $1.12M | ($752.00M) |
| Operating Income | $0.79M | $1.18M | $0.20M | ($0.50M) | ($296.00M) |
| Operating Margin %(computed) | 33.32% | 48.03% | 10.26% | -53.81% | -64.91% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | ($36.00M) |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $73.00M |
| Income Before Tax | $0.79M | $1.18M | $0.19M | ($0.48M) | ($273.00M) |
| Income Tax Expense | $0.31M | $0.33M | ($0.00M) | $0.00M | ($79.00M) |
| Net Income | $0.48M | $0.85M | $0.19M | ($0.48M) | ($194.00M) |
| Net Margin %(computed) | 20.09% | 34.65% | 9.97% | -52.09% | -42.54% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.02 | $0.03 | $0.01 | $-0.02 | $-4.14 |
| Wtd Avg Shares | 26.20M | 26.20M | 26.20M | 26.20M | 46.91M |
| EBITDA | $0.82M | $1.20M | $0.22M | ($0.45M) | ($282.00M) |
| EBITDA Margin %(computed) | 34.27% | 48.84% | 11.50% | -47.80% | -61.84% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M
深入了解Park Ha Biological Technology Co., Ltd.
关于Park Ha Biological Technology Co., Ltd.(PHH)损益表
Park Ha Biological Technology Co., Ltd.(PHH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,PHH实现营收$0.00B,毛利润$0.00B(毛利率91.81%),净利润$0.00B(净利率20.09%)。
常见问题
PHH · 4 问Park Ha Biological Technology Co., Ltd.(PHH)2024财年营收为$0.00B,同比down3.1%。
PHH revenuePHH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08